Myocardial infarction (MI) is the main complication of coronary artery disease (CAD). Recently, a locus tagging the *GUCY1A3* gene has been shown to be genome-wide significantly associated with CAD \[[@B1]\]. *GUCY1A3* encodes for the α~1~-subunit of the soluble guanylyl cyclase (sGC) which consists of α~1~- and β~1~-subunits and catalyzes the production of cGMP upon stimulation with nitric oxide (NO). cGMP acts a second messenger that mediates diverse cellular functions, e.g. smooth muscle relaxation and inhibition of platelet aggregation. Using whole-exome sequencing, our group also identified nine rare variants in the coding sequence of *GUCY1A3* \[[@B2]\]. Two of these variants were found in two extended families with a high prevalence of premature CAD/MI. Seven further rare variants were found in 252 young MI patients. In this study, we aimed to investigate the functional implication of these rare variants found in CAD/MI patients (Table [1](#T1){ref-type="table"}) regarding protein level, dimerization capability and enzymatic activity.

###### 

Rare variants of sGC α1 subunit found in MI patients:

  ------------------- -------------------- -------------------------------------- ------------------------- -------------
  Variant             Identified in        Predicted effect on protein function                             
                                                                                                            
                                           PolyPhen-2                             SIFT                      SNAP
  p.Leu163Phefs\*24   MI family            frameshift                             \-                        \-
  p.Lys53Glu          252 young MI cases   possibly damaging damaging             tolerated                 non-neutral
  p.Thr64Ala          252 young MI cases   benign                                 tolerated                 neutral
  p.Thr229Met         252 young MI cases   possibly damaging                      tolerated                 non-neutral
  p.Ser478Gly         252 young MI cases   benign                                 tolerated                 neutral
  p.Val587Ile         252 young MI cases   benign                                 tolerated                 neutral
  p.Gly573Arg         MI family            probably damaging                      affect protein function   non-neutral
  p.Cys610Tyr         252 young MI cases   probably damaging                      tolerated                 neutral
  p.Ile571Val         252 young MI cases   possibly damaging                      affect protein function   neutral
  ------------------- -------------------- -------------------------------------- ------------------------- -------------

Two of the investigated α~1~ variants exhibited significantly decreased protein levels compared to wild type α~1~. The amount of β~1~ correlated with those of α~1~ in all cases. All α~1~ variants, except for p.Leu163Phefs\*24, still dimerized with the β~1~ subunit, as shown by co-immunoprecipitation. Using radioimmunoassay three of the rare variants demonstrated significantly decreased cGMP amounts at every time point tested (0.5/1/2 min). The activity only in part correlated with the observed protein levels pointing to an effect of the tested variants on enzymatic activity. As we have shown that loss of function-mutations in *GUCY1A3* may lead to CAD/MI \[[@B2]\], decreased enzymatic activity might also increase risk. Future studies focus on mRNA abundance and protein degradation to uncover the reason for attenuated activity of the respective variants.
